Literature DB >> 17075129

Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Zsolt Keresztessy1, Eva Csosz, Jolán Hársfalvi, Krisztián Csomós, Joe Gray, Robert N Lightowlers, Jeremy H Lakey, Zoltán Balajthy, László Fésüs.   

Abstract

Understanding substrate specificity and identification of natural targets of transglutaminase 2 (TG2), the ubiquitous multifunctional cross-linking enzyme, which forms isopeptide bonds between protein-linked glutamine and lysine residues, is crucial in the elucidation of its physiological role. As a novel means of specificity analysis, we adapted the phage display technique to select glutamine-donor substrates from a random heptapeptide library via binding to recombinant TG2 and elution with a synthetic amine-donor substrate. Twenty-six Gln-containing sequences from the second and third biopanning rounds were susceptible for TG2-mediated incorporation of 5-(biotinamido)penthylamine, and the peptides GQQQTPY, GLQQASV, and WQTPMNS were modified most efficiently. A consensus around glutamines was established as pQX(P,T,S)l, which is consistent with identified substrates listed in the TRANSDAB database. Database searches showed that several proteins contain peptides similar to the phage-selected sequences, and the N-terminal glutamine-rich domain of SWI1/SNF1-related chromatin remodeling proteins was chosen for detailed analysis. MALDI/TOF and tandem mass spectrometry-based studies of a representative part of the domain, SGYGQQGQTPYYNQQSPHPQQQQPPYS (SnQ1), revealed that Q(6), Q(8), and Q(22) are modified by TG2. Kinetic parameters of SnQ1 transamidation (K(M)(app) = 250 microM, k(cat) = 18.3 sec(-1), and k(cat)/K(M)(app) = 73,200) classify it as an efficient TG2 substrate. Circular dichroism spectra indicated that SnQ1 has a random coil conformation, supporting its accessibility in the full-length parental protein. Added together, here we report a novel use of the phage display technology with great potential in transglutaminase research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075129      PMCID: PMC2242420          DOI: 10.1110/ps.051818406

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

1.  Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides.

Authors:  P J Coussons; N C Price; S M Kelly; B Smith; L Sawyer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.

Authors:  Felix Hausch; Tuula Halttunen; Markku Mäki; Chaitan Khosla
Journal:  Chem Biol       Date:  2003-03

Review 3.  Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.

Authors:  Carla Esposito; Ivana Caputo
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

4.  Core histones are glutaminyl substrates for tissue transglutaminase.

Authors:  E Ballestar; C Abad; L Franco
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

5.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches.

Authors:  H P Gerber; K Seipel; O Georgiev; M Höfferer; M Hug; S Rusconi; W Schaffner
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

6.  Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes.

Authors:  D Aeschlimann; M Paulsson; K Mann
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

7.  Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease.

Authors:  G Andringa; K Y Lam; M Chegary; X Wang; T N Chase; M C Bennett
Journal:  FASEB J       Date:  2004-03-04       Impact factor: 5.191

8.  Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice.

Authors:  L Piredda; A Amendola; V Colizzi; P J Davies; M G Farrace; M Fraziano; V Gentile; I Uray; M Piacentini; L Fesus
Journal:  Cell Death Differ       Date:  1997-08       Impact factor: 15.828

9.  Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.

Authors:  Burkhard Fleckenstein; Shuo-Wang Qiao; Martin R Larsen; Günther Jung; Peter Roepstorff; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

10.  Active Sequences Collection (ASC) database: a new tool to assign functions to protein sequences.

Authors:  Angelo M Facchiano; Antonio Facchiano; Francesco Facchiano
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  12 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Substrates, inhibitors, and probes of mammalian transglutaminase 2.

Authors:  Ruize Zhuang; Chaitan Khosla
Journal:  Anal Biochem       Date:  2019-12-24       Impact factor: 3.365

3.  Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library.

Authors:  Yoshiaki Sugimura; Hiroyuki Yamashita; Kiyotaka Hitomi
Journal:  Cytotechnology       Date:  2010-09-25       Impact factor: 2.058

4.  Naturally Occurring Epsilon Gamma Glutamyl Lysine Isopeptide Crosslinks in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Oksana Lockridge; Lawrence M Schopfer
Journal:  ACS Omega       Date:  2022-06-16

5.  Method for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries.

Authors:  Bi-Huang Hu; Marsha Ritter Jones; Phillip B Messersmith
Journal:  Anal Chem       Date:  2007-08-23       Impact factor: 6.986

6.  Rapid interactome profiling by massive sequencing.

Authors:  Roberto Di Niro; Ana-Marija Sulic; Flavio Mignone; Sara D'Angelo; Roberta Bordoni; Michele Iacono; Roberto Marzari; Tiziano Gaiotto; Miha Lavric; Andrew R M Bradbury; Luigi Biancone; Dina Zevin-Sonkin; Gianluca De Bellis; Claudio Santoro; Daniele Sblattero
Journal:  Nucleic Acids Res       Date:  2010-02-09       Impact factor: 16.971

Review 7.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

8.  Facile coupling of synthetic peptides and peptide-polymer conjugates to cartilage via transglutaminase enzyme.

Authors:  Marsha Elizabeth Ritter Jones; Phillip B Messersmith
Journal:  Biomaterials       Date:  2007-09-17       Impact factor: 12.479

Review 9.  Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.

Authors:  Chen Liu; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

10.  Infection-driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells.

Authors:  Benoit Maffei; Marc Laverrière; Yongzheng Wu; Sébastien Triboulet; Stéphanie Perrinet; Magalie Duchateau; Mariette Matondo; Robert L Hollis; Charlie Gourley; Jan Rupp; Jeffrey W Keillor; Agathe Subtil
Journal:  EMBO J       Date:  2020-03-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.